Europe Intravenous-to-Subcutaneous Drug Market Report 2017
- QYR1018720
- 103 Pages
- March 2017
- Pharmaceuticals
Sales, means the sales volume of Intravenous-to-Subcutaneous Drug
Revenue, means the sales value of Intravenous-to-Subcutaneous Drug
This report studies sales (consumption) of Intravenous-to-Subcutaneous Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Baxter
Britannia
Capricor
CSL Behring
GlaxoSmithKline
Grifols
Ferring
Janssen
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Intravenous-to-Subcutaneous Drug in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Intravenous-to-Subcutaneous Drug in each application, can be divided into
Application 1
Application 2
Europe Intravenous-to-Subcutaneous Drug Market Report 2017
1 Intravenous-to-Subcutaneous Drug Overview
1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
1.2 Classification of Intravenous-to-Subcutaneous Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Intravenous-to-Subcutaneous Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Intravenous-to-Subcutaneous Drug Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drug (2012-2022)
1.5.1 Europe Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2022)
1.5.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
2 Europe Intravenous-to-Subcutaneous Drug by Manufacturers, Type and Application
2.1 Europe Intravenous-to-Subcutaneous Drug Market Competition by Manufacturers
2.1.1 Europe Intravenous-to-Subcutaneous Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Intravenous-to-Subcutaneous Drug (Volume and Value) by Type
2.2.1 Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Type (2012-2017)
2.2.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
2.3 Europe Intravenous-to-Subcutaneous Drug (Volume and Value) by Countries
2.3.1 Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Market Share by Countries (2012-2017)
2.4 Europe Intravenous-to-Subcutaneous Drug (Volume) by Application
3 Germany Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
3.1 Germany Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
3.1.1 Germany Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
3.1.2 Germany Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
3.1.3 Germany Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
3.2 Germany Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
3.3 Germany Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
3.4 Germany Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
4 France Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
4.1 France Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
4.1.1 France Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
4.1.2 France Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
4.1.4 France Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
4.2 France Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
4.3 France Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
4.4 France Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
5 UK Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
5.1 UK Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
5.1.1 UK Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
5.1.2 UK Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
5.1.5 UK Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
5.2 UK Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
5.3 UK Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
5.4 UK Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
6 Russia Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
6.1 Russia Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
6.1.1 Russia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
6.1.2 Russia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
6.1.6 Russia Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
6.2 Russia Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
6.3 Russia Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
6.4 Russia Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
7 Italy Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
7.1 Italy Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
7.1.1 Italy Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
7.1.2 Italy Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
7.1.7 Italy Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
7.2 Italy Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
7.3 Italy Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
7.4 Italy Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
8 Spain Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
8.1 Spain Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
8.1.1 Spain Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
8.1.2 Spain Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
8.1.8 Spain Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
8.2 Spain Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
8.3 Spain Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
8.4 Spain Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
9 Benelux Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
9.1 Benelux Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
9.1.1 Benelux Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
9.1.2 Benelux Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
9.2 Benelux Intravenous-to-Subcutaneous Drug Sales and Market Share by Manufacturers
9.3 Benelux Intravenous-to-Subcutaneous Drug Sales and Market Share by Type
9.4 Benelux Intravenous-to-Subcutaneous Drug Sales and Market Share by Application
10 Europe Intravenous-to-Subcutaneous Drug Manufacturers Analysis
10.1 Baxter
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Baxter Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Britannia
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Britannia Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Capricor
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Capricor Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 CSL Behring
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 CSL Behring Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 GlaxoSmithKline
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 GlaxoSmithKline Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Grifols
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Grifols Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Ferring
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Ferring Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Janssen
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Intravenous-to-Subcutaneous Drug Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Janssen Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
11 Intravenous-to-Subcutaneous Drug Manufacturing Cost Analysis
11.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Intravenous-to-Subcutaneous Drug Market Forecast (2017-2022)
14.1 Germany Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.2 France Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.3 UK Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.4 Russia Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.5 Italy Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.6 Spain Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.7 Benelux Intravenous-to-Subcutaneous Drug Sales Forecast (2017-2022)
14.8 Europe Intravenous-to-Subcutaneous Drug Sales Forecast by Type (2017-2022)
14.9 Europe Intravenous-to-Subcutaneous Drug Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Intravenous-to-Subcutaneous Drug
Table Classification of Intravenous-to-Subcutaneous Drug
Figure Europe Sales Market Share of Intravenous-to-Subcutaneous Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Intravenous-to-Subcutaneous Drug
Figure Europe Sales Market Share of Intravenous-to-Subcutaneous Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure France Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure UK Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure Russia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure Italy Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure Spain Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure Benelux Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2022)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)
Table Europe Intravenous-to-Subcutaneous Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous-to-Subcutaneous Drug Sales Share by Manufacturers
Figure 2016 Intravenous-to-Subcutaneous Drug Sales Share by Manufacturers
Table Europe Intravenous-to-Subcutaneous Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
Table 2016 Europe Intravenous-to-Subcutaneous Drug Revenue Share by Manufacturers
Table Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Sales Growth Rate by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Type (2012-2017)
Figure Europe Intravenous-to-Subcutaneous Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Intravenous-to-Subcutaneous Drug by Countries (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales and Market Share by Application (2012-2017)
Table Europe Intravenous-to-Subcutaneous Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Intravenous-to-Subcutaneous Drug by Application (2012-2017)
Figure Germany Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure Germany Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure Germany Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table Germany Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table Germany Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table Germany Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table Germany Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table Germany Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure France Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure France Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure France Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table France Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table France Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table France Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table France Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table France Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table France Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure UK Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure UK Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure UK Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table UK Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table UK Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table UK Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table UK Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table UK Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table UK Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure Russia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure Russia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure Russia Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table Russia Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table Russia Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table Russia Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table Russia Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table Russia Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure Italy Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure Italy Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure Italy Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table Italy Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table Italy Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table Italy Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table Italy Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table Italy Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure Spain Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure Spain Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure Spain Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table Spain Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table Spain Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table Spain Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table Spain Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table Spain Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Figure Benelux Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
Figure Benelux Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
Table Benelux Intravenous-to-Subcutaneous Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Intravenous-to-Subcutaneous Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Intravenous-to-Subcutaneous Drug Sales by Type (2015 and 2016)
Table Benelux Intravenous-to-Subcutaneous Drug Market Share by Type (2015 and 2016)
Table Benelux Intravenous-to-Subcutaneous Drug Sales by Application (2015 and 2016)
Table Benelux Intravenous-to-Subcutaneous Drug Market Share by Application (2015 and 2016)
Table Intravenous-to-Subcutaneous Drug Basic Information List
Table Baxter Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Baxter Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Britannia Basic Information List
Table Britannia Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Britannia Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Capricor Basic Information List
Table Capricor Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Capricor Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Behring Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Grifols Basic Information List
Table Grifols Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Grifols Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Ferring Basic Information List
Table Ferring Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Janssen Basic Information List
Table Janssen Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Intravenous-to-Subcutaneous Drug Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous-to-Subcutaneous Drug
Figure Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
Figure Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
Table Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2015
Table Major Buyers of Intravenous-to-Subcutaneous Drug
Table Distributors/Traders List
Figure Germany Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure Germany Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure France Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure France Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure UK Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure UK Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure Russia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure Italy Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure Spain Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Intravenous-to-Subcutaneous Drug Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
Table Europe Intravenous-to-Subcutaneous Drug Sales Forecast by Type (2017-2022)
Table Europe Intravenous-to-Subcutaneous Drug Sales Forecast by Application (2017-2022)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
